SCHEDULE: Vanguard Group Discloses 5.43% Stake in USANA Health Sciences

The Vanguard Group has filed an amendment to its Schedule 13G, reporting a beneficial ownership of 5.43% in USANA Health Sciences Inc.'s common stock.

Summary

• The Vanguard Group reported beneficial ownership of 1,011,783 shares of USANA Health Sciences Inc. common stock.
• This ownership represents 5.43% of the total class of securities.
• Vanguard holds sole dispositive power over 958,721 shares and shared dispositive power over 53,062 shares.
• Vanguard has shared voting power over 41,605 shares and no sole voting power.
• The filing is an Amendment No. 7 to a Schedule 13G, indicating an update to a previously reported ownership position.

Sentiment

Score: 5

Explanation: The filing is a routine disclosure of beneficial ownership by a large institutional investor, indicating a neutral sentiment regarding the issuer's operational performance or strategic direction.

Future Outlook

NA

Management Comments

• The securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under Rule 14a-11.

Industry Context

NA

Stakeholder Impact

• Shareholders: Provides transparency regarding a significant institutional ownership stake, which can influence market perception and liquidity.

Key Dates

Keywords

USANA Health Sciences, Vanguard Group, Schedule 13G, Beneficial Ownership, Common Stock, Investment Adviser, Institutional Investor